FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
PeerJ2016; 4; e1773; doi: 10.7717/peerj.1773

Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses.

Abstract: Background. Mesenchymal stromal cells (MSCs) are increasingly used for clinical applications in equine patients. For MSC isolation and expansion, a laboratory step is mandatory, after which the cells are sent back to the attending veterinarian. Preserving the biological properties of MSCs during this transport is paramount. The goal of the study was to compare transport-related parameters (transport container, media, temperature, time, cell concentration) that potentially influence characteristics of culture expanded equine MSCs. Methods. The study was arranged in three parts comparing (I) five different transport containers (cryotube, two types of plastic syringes, glass syringe, CellSeal), (II) seven different transport media, four temperatures (4 °C vs. room temperature; -20 °C vs. -80 °C), four time frames (24 h vs. 48 h; 48 h vs. 72 h), and (III) three MSC concentrations (5 × 10(6), 10 × 10(6), 20 × 10(6) MSC/ml). Cell viability (Trypan Blue exclusion; percent and total number viable cell), proliferation and trilineage differentiation capacity were assessed for each test condition. Further, the recovered volume of the suspension was determined in part I. Each condition was evaluated using samples of six horses (n = 6) and differentiation protocols were performed in duplicates. Results. In part I of the study, no significant differences in any of the parameters were found when comparing transport containers at room temperature. The glass syringe was selected for all subsequent evaluations (highest recoverable volume of cell suspension and cell viability). In part II, media, temperatures, or time frames had also no significant influence on cell viability, likely due to the large number of comparisons and small sample size. Highest cell viability was observed using autologous bone marrow supernatant as transport medium, and "transport" at 4 °C for 24 h (70.6% vs. control group 75.3%); this was not significant. Contrary, viability was unacceptably low (<40%) for all freezing protocols at -20 °C or -80 °C, particularly with bone marrow supernatant or plasma and DMSO. In part III, various cell concentrations also had no significant influence on any of the evaluated parameters. Chondrogenic differentiation showed a trend towards being decreased for all transport conditions, compared to control cells. Discussion. In this study, transport conditions were not found to impact viability, proliferation or ability for trilineage differentiation of MSCs, most likely due to the small sample size and large number of comparisons. The unusual low viability after all freezing protocols is in contrast to previous equine studies. Potential causes are differences in the freezing, but also in thawing method. Also, the selected container (glass syringe) may have impacted viability. Future research may be warranted into the possibly negative effect of transport on chondrogenic differentiation.
Get Full Text
Publication Date: 2016-03-22 PubMed ID: 27019778PubMed Central: PMC4806605DOI: 10.7717/peerj.1773Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research studied the impact of different transport conditions on the viability of horse bone marrow-derived mesenchymal stromal cells (MSCs) and found that, despite common assumptions, the cells demonstrated remarkable resilience to a variety of conditions.

Research Overview

  • The research focused on investigating the impact of different transport conditions on the biological properties of mesenchymal stromal cells (MSCs) derived from the bone marrow of horses. These cells are frequently used in equine treatments.
  • The study tested a range of transport-related parameters including the container used for cell transportation, the medium cells were immersed in, the length of time cells were transported, the temperature during transportation, and the concentration of cells.
  • The research was split into three parts; each examining different factors around transport of stem cells.

Study Methodology

  • The first part of the study compared five different types of transport containers to evaluate their impact on the characteristics of the MSCs.
  • The second part tested seven different transport media, two different temperatures and four different time frames.
  • The third part of the study examined the impact of three different cell concentrations.
  • The cell viability, proliferation potential, and trilineage differentiation capacity were assessed under each test condition.

Results

  • The first part of the study found no significant differences between any of the transport containers when kept at room temperature.
  • The second part of the study found that neither media, temperatures, or time frames had a significant influence on cell viability.
  • The third part of the study demonstrated that different cell concentrations also had no appreciable impact on the measured parameters.
  • However, it was observed that all freezing protocols resulted in unacceptably low viability, particularly with bone marrow supernatant or plasma and DMSO.
  • A trend of decreased chondrogenic differentiation was observed under all transport conditions.

Discussion

  • The results of this study suggest that the transport conditions had minimal influence on the viability, proliferation or trilineage differentiation capabilities of MSCs. This is unexpected as the vulnerability of the cells to changes in their environment is often assumed.
  • The study also highlighted potential issues with freezing protocols and their impact on cell viability. This suggests that variations in freezing or thawing methods could be a factor and warrants further investigation.
  • Additionally, the significance of the decreased chondrogenic differentiation should be explored in the future.

Cite This Article

APA
Espina M, Jülke H, Brehm W, Ribitsch I, Winter K, Delling U. (2016). Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses. PeerJ, 4, e1773. https://doi.org/10.7717/peerj.1773

Publication

PeerJ
ISSN: 2167-8359
NlmUniqueID: 101603425
Country: United States
Language: English
Volume: 4
Pages: e1773
PII: e1773

Researcher Affiliations

Espina, Miguel
  • Large Animal Clinic for Surgery, Faculty of Veterinary Medicine, University of Leipzig , Leipzig , Germany.
Jülke, Henriette
  • Translational Centre for Regenerative Medicine (TRM), University of Leipzig , Leipzig , Germany.
Brehm, Walter
  • Large Animal Clinic for Surgery, Faculty of Veterinary Medicine, University of Leipzig , Leipzig , Germany.
Ribitsch, Iris
  • Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany; Equine Clinic, University of Veterinary Medicine Vienna, Vienna, Austria.
Winter, Karsten
  • Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany; Institute of Anatomy, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Delling, Uta
  • Large Animal Clinic for Surgery, Faculty of Veterinary Medicine, University of Leipzig , Leipzig , Germany.

Conflict of Interest Statement

The authors declare there are no competing interests.

References

This article includes 31 references
  1. Almodóvar J, Bacon S, Gogolski J, Kisiday JD, Kipper MJ. Polysaccharide-based polyelectrolyte multilayer surface coatings can enhance mesenchymal stem cell response to adsorbed growth factors.. Biomacromolecules 2010 Oct 11;11(10):2629-39.
    doi: 10.1021/bm1005799pubmed: 20795698google scholar: lookup
  2. Bronzini I, Patruno M, Iacopetti I, Martinello T. Influence of temperature, time and different media on mesenchymal stromal cells shipped for clinical application.. Vet J 2012 Oct;194(1):121-3.
    doi: 10.1016/j.tvjl.2012.03.010pubmed: 22503718google scholar: lookup
  3. Costa E, Usall J, Teixidó N, Garcia N, Viñas I. Effect of protective agents, rehydration media and initial cell concentration on viability of Pantoea agglomerans strain CPA-2 subjected to freeze-drying.. J Appl Microbiol 2000 Nov;89(5):793-800.
    pubmed: 11119153doi: 10.1046/j.1365-2672.2000.01182.xgoogle scholar: lookup
  4. De Loecker W, Koptelov VA, Grischenko VI, De Loecker P. Effects of cell concentration on viability and metabolic activity during cryopreservation.. Cryobiology 1998 Sep;37(2):103-9.
    doi: 10.1006/cryo.1998.2106pubmed: 9769160google scholar: lookup
  5. Delling U, Lindner K, Ribitsch I, Jülke H, Brehm W. Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses.. Can J Vet Res 2012 Jan;76(1):52-6.
    pmc: PMC3244288pubmed: 22754095
  6. Dlimi A. Einfluss der Konzentration unterschiedlicher Zellpopulationen auf die Vitalität kryokonservierter Stammzellkonzentrate. Dissertation Dr.med. Erlangen: University of Erlangen-Nürnberg; 2012.
  7. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD, Schneider RK, Zubrod CJ, Kawcak CE, Goodrich LR. Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury.. Vet Surg 2014 Mar;43(3):255-65.
    doi: 10.1111/j.1532-950X.2014.12100.xpubmed: 24433318google scholar: lookup
  8. François M, Copland IB, Yuan S, Romieu-Mourez R, Waller EK, Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.. Cytotherapy 2012 Feb;14(2):147-52.
    doi: 10.3109/14653249.2011.623691pmc: PMC3279133pubmed: 22029655google scholar: lookup
  9. Garvican ER, Cree S, Bull L, Smith RK, Dudhia J. Viability of equine mesenchymal stem cells during transport and implantation.. Stem Cell Res Ther 2014 Aug 8;5(4):94.
    doi: 10.1186/scrt483pmc: PMC4247703pubmed: 25107289google scholar: lookup
  10. Gerhardt A, Mcgraw NR, Schwartz DK, Bee JS, Carpenter JF, Randolph TW. Protein aggregation and particle formation in prefilled glass syringes.. J Pharm Sci 2014 Jun;103(6):1601-12.
    doi: 10.1002/jps.23973pubmed: 24729310google scholar: lookup
  11. Giard DJ. Routine heat inactivation of serum reduces its capacity to promote cell attachment.. In Vitro Cell Dev Biol 1987 Oct;23(10):691-7.
    doi: 10.1007/BF02620982pubmed: 3667489google scholar: lookup
  12. Giovannini S, Brehm W, Mainil-Varlet P, Nesic D. Multilineage differentiation potential of equine blood-derived fibroblast-like cells.. Differentiation 2008 Feb;76(2):118-29.
    doi: 10.1111/j.1432-0436.2007.00207.xpubmed: 17697129google scholar: lookup
  13. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  14. Grogan SP, Barbero A, Winkelmann V, Rieser F, Fitzsimmons JS, O'Driscoll S, Martin I, Mainil-Varlet P. Visual histological grading system for the evaluation of in vitro-generated neocartilage.. Tissue Eng 2006 Aug;12(8):2141-9.
    doi: 10.1089/ten.2006.12.2141pubmed: 16968155google scholar: lookup
  15. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, Purpari G, Di Bella S, Piccione G. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints.. Cell Biol Int 2012 Feb;36(2):189-94.
    doi: 10.1042/CBI20110304pubmed: 21936851google scholar: lookup
  16. Jones LS, Kaufmann A, Middaugh CR. Silicone oil induced aggregation of proteins.. J Pharm Sci 2005 Apr;94(4):918-27.
    doi: 10.1002/jps.20321pubmed: 15736189google scholar: lookup
  17. Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, Mahmut N, Shinagawa K, Omoto E, Makino S, Miyamoto T, Mizuno S, Fukuda T, Eto T, Fujisaki T, Ohno Y, Inaba S, Niho Y, Harada M. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells.. Bone Marrow Transplant 1997 Feb;19(3):283-7.
    doi: 10.1038/sj.bmt.1700644pubmed: 9028559google scholar: lookup
  18. Lioznov M, Dellbrügger C, Sputtek A, Fehse B, Kröger N, Zander AR. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM.. Bone Marrow Transplant 2008 Jul;42(2):121-8.
    doi: 10.1038/bmt.2008.93pubmed: 18391988google scholar: lookup
  19. Mercati F, Pascucci L, Curina G, Scocco P, Tardella FM, Dall'aglio C, Marini C, Ceccarelli P. Evaluation of storage conditions on equine adipose tissue-derived multipotent mesenchymal stromal cells.. Vet J 2014 May;200(2):339-42.
    doi: 10.1016/j.tvjl.2014.02.018pubmed: 24656629google scholar: lookup
  20. Mitchell A, Rivas KA, Smith R 3rd, Watts AE. Cryopreservation of equine mesenchymal stem cells in 95% autologous serum and 5% DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95% and DMSO at 10 or 5.. Stem Cell Res Ther 2015 Nov 26;6:231.
    doi: 10.1186/s13287-015-0230-ypmc: PMC4661990pubmed: 26611913google scholar: lookup
  21. Phelan MC. Basic techniques in mammalian cell tissue culture.. Curr Protoc Cell Biol 2007 Sep;Chapter 1:Unit 1.1.
    doi: 10.1002/0471143030.cb0101s36pubmed: 18228494google scholar: lookup
  22. Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.. Vet Comp Orthop Traumatol 2013;26(6):453-60.
    doi: 10.3415/VCOT-13-01-0008pubmed: 24080668google scholar: lookup
  23. Seo JP, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y, Sasaki N. Comparison of allogeneic platelet lysate and fetal bovine serum for in vitro expansion of equine bone marrow-derived mesenchymal stem cells.. Res Vet Sci 2013 Oct;95(2):693-8.
    doi: 10.1016/j.rvsc.2013.04.024pubmed: 23683731google scholar: lookup
  24. Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.. Transfusion 2014 May;54(5):1418-37.
    doi: 10.1111/trf.12421pmc: PMC6364749pubmed: 24898458google scholar: lookup
  25. Smith RK, Garvican ER, Fortier LA. The current 'state of play' of regenerative medicine in horses: what the horse can tell the human.. Regen Med 2014;9(5):673-85.
    doi: 10.2217/rme.14.42pubmed: 25372081google scholar: lookup
  26. Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.. PLoS One 2013;8(9):e75697.
    doi: 10.1371/journal.pone.0075697pmc: PMC3783421pubmed: 24086616google scholar: lookup
  27. Sundin M, Ringdén O, Sundberg B, Nava S, Götherström C, Le Blanc K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.. Haematologica 2007 Sep;92(9):1208-15.
    doi: 10.3324/haematol.11446pubmed: 17666368google scholar: lookup
  28. Thirumala S, Goebel WS, Woods EJ. Manufacturing and banking of mesenchymal stem cells.. Expert Opin Biol Ther 2013 May;13(5):673-91.
    doi: 10.1517/14712598.2013.763925pubmed: 23339745google scholar: lookup
  29. Wang PY, Clements LR, Thissen H, Tsai WB, Voelcker NH. Screening rat mesenchymal stem cell attachment and differentiation on surface chemistries using plasma polymer gradients.. Acta Biomater 2015 Jan;11:58-67.
    doi: 10.1016/j.actbio.2014.09.027pubmed: 25246312google scholar: lookup
  30. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons.. J Neurosci Res 2000 Aug 15;61(4):364-70.
    doi: 10.1002/1097-4547(20000815)61:4¡364::AID-JNR2¿3.0.CO;2-Cpubmed: 10931522google scholar: lookup
  31. Young DA, Gavrilov S, Pennington CJ, Nuttall RK, Edwards DR, Kitsis RN, Clark IM. Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes.. Biochem Biophys Res Commun 2004 Sep 24;322(3):759-65.
    doi: 10.1016/j.bbrc.2004.07.178pubmed: 15336529google scholar: lookup

Citations

This article has been cited 10 times.
  1. Yasumura Y, Teshima T, Taira Y, Saito T, Yuchi Y, Suzuki R, Matsumoto H. Optimal Intravenous Administration Procedure for Efficient Delivery of Canine Adipose-Derived Mesenchymal Stem Cells. Int J Mol Sci 2022 Nov 24;23(23).
    doi: 10.3390/ijms232314681pubmed: 36499004google scholar: lookup
  2. Iacono E, Merlo B. Stem Cells in Domestic Animals: Applications in Health and Production. Animals (Basel) 2022 Oct 13;12(20).
    doi: 10.3390/ani12202753pubmed: 36290139google scholar: lookup
  3. Iacono E, Lanci A, Gugole P, Merlo B. Shipping Temperature, Time and Media Effects on Equine Wharton's Jelly and Adipose Tissue Derived Mesenchymal Stromal Cells Characteristics. Animals (Basel) 2022 Aug 3;12(15).
    doi: 10.3390/ani12151967pubmed: 35953956google scholar: lookup
  4. Mocchi M, Dotti S, Bue MD, Villa R, Bari E, Perteghella S, Torre ML, Grolli S. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?. Cells 2020 Jun 11;9(6).
    doi: 10.3390/cells9061453pubmed: 32545382google scholar: lookup
  5. Zickri MB, Sadek EM, Fares AE, Heteba NG, Reda AM. Effect of Stem Cells, Ascorbic Acid and SERCA1a Gene Transfected Stem Cells in Experimentally Induced Type I Diabetic Myopathy. Int J Stem Cells 2020 Mar 30;13(1):163-175.
    doi: 10.15283/ijsc18066pubmed: 32114738google scholar: lookup
  6. Drela K, Stanaszek L, Nowakowski A, Kuczynska Z, Lukomska B. Experimental Strategies of Mesenchymal Stem Cell Propagation: Adverse Events and Potential Risk of Functional Changes. Stem Cells Int 2019;2019:7012692.
    doi: 10.1155/2019/7012692pubmed: 30956673google scholar: lookup
  7. Zickri MB, Aboul-Fotouh GI, Omar AI, El-Shafei AA, Reda AM. Effect of Stem Cells and Gene Transfected Stem Cells Therapy on the Pancreas of Experimentally Induced Type 1 Diabetes. Int J Stem Cells 2018 Nov 30;11(2):205-215.
    doi: 10.15283/ijsc18002pubmed: 30021252google scholar: lookup
  8. Zhang F, Ren H, Shao X, Zhuang C, Chen Y, Qi N. Preservation media, durations and cell concentrations of short-term storage affect key features of human adipose-derived mesenchymal stem cells for therapeutic application. PeerJ 2017;5:e3301.
    doi: 10.7717/peerj.3301pubmed: 28533959google scholar: lookup
  9. Andreoli V, Berni P, Conti V, Ramoni R, Basini G, Grolli S. Mesenchymal Stromal Cells Derived from Canine Adipose Tissue: Evaluation of the Effect of Different Shipping Vehicles Used for Clinical Administration. Int J Mol Sci 2024 Mar 18;25(6).
    doi: 10.3390/ijms25063426pubmed: 38542399google scholar: lookup
  10. Burk J, Wittenberg-Voges L, Schubert S, Horstmeier C, Brehm W, Geburek F. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses. Cells 2023 Oct 24;12(21).
    doi: 10.3390/cells12212513pubmed: 37947591google scholar: lookup
Subscribe to our newsletter
Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.